Overview

An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder

Status:
Completed

Trial end date:
2016-07-01

Target enrollment:

Participant gender:

Summary

This is an open-label pilot study of adjunctive asenapine for the treatment of Posttraumatic Stress Disorder (PTSD) in veterans who have not fully remitted to an adequate trial of standard antidepressant treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Lori Davis, MD

Collaborators:

Forest Laboratories
Merck Sharp & Dohme Corp.

Treatments:

Antidepressive Agents
Asenapine